FDA lays out 2021 regulatory science areas of focus
January 18, 2021 The Focus Areas of Regulatory Science (FARS) issued on in mid-January 2021 “outlines topics that the FDA has identified as needing continued targeted investment in regulatory science research to facilitate the development of innovative products, provide data and methodology to inform regulatory decision-making and improve guidance to sponsors,” according to FDA Chief … Read more